Invitae Expanded Renal Disease Panel
Use
The Invitae Expanded Renal Disease Panel analyzes genes associated with renal disorders such as Alport syndrome, FSGS, nephrotic syndrome, and renal tubular disorders. Genetic testing can confirm diagnoses, guide treatment, and aid in at-risk relatives' testing. Some genes may relate to additional disorders not listed here.
Special Instructions
The test does not include the PKD1 gene, which is significant for autosomal dominant polycystic kidney disease, type 1. Additional testing for PKD1 should be considered if appropriate.
Limitations
This assay does not cover the PKD1 gene and certain genomic variants such as structural rearrangements may not be detected. Some gene regions or variant types may be excluded. The patient’s blood DNA may not represent the constitutional genome if affected by certain conditions.
New York Approved
Methodology
NGS (CGP)
Biomarkers
Result Turnaround Time
10-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3mL
Minimum Volume
Not provided
Container
purple-top EDTA tube (K2EDTA or K3EDTA)
Other tests from different labs that may be relevant